PMID- 11368255
OWN - NLM
STAT- MEDLINE
DCOM- 20011011
LR  - 20181113
IS  - 1064-7449 (Print)
IS  - 1098-0997 (Electronic)
IS  - 1064-7449 (Linking)
VI  - 9
IP  - 1
DP  - 2001
TI  - Survey of obstetrician-gynecologists in the United States about toxoplasmosis.
PG  - 23-31
AB  - BACKGROUND: Although the incidence of toxoplasmosis is low in the United States, 
      up to 6000 congenital cases occur annually. In September 1998, the Centers for 
      Disease Control and Prevention held a conference about toxoplasmosis; 
      participants recommended a survey of the toxoplasmosis-related knowledge and 
      practices of obstetrician-gynecologists and the development of professional 
      educational materials for them. METHODS: In the fall of 1999, surveys were mailed 
      to a 2% random sample of American College of Obstetricians and Gynecologists 
      (ACOG) members and to a demographically representative group of ACOG members 
      known as the Collaborative Ambulatory Research Network (CARN). Responses were not 
      significantly different for the random and CARN groups for most questions (p 
      value shown when different). RESULTS: Among 768 US practicing ACOG members 
      surveyed, 364 (47%) responded. Seven per cent (CARN 10%, random 5%) had diagnosed 
      one or more case(s) of acute toxoplasmosis in the past year. Respondents were 
      well-informed about how to prevent toxoplasmosis. However, only 12% (CARN 11%, 
      random 12%) indicated that a positive Toxoplasma IgM test might be a 
      false-positive result, and only 11% (CARN 14%, random 9%) were aware that the 
      Food and Drug Administration sent an advisory to all ACOG members in 1997 stating 
      that some Toxoplasma IgM test kits have high false-positive rates. Most of those 
      surveyed (CARN 70%, random 59%; chi2 p < 0.05) were opposed to universal 
      screening of pregnant women. CONCLUSIONS: Many US obstetrician-gynecologists will 
      encounter acute toxoplasmosis during their careers, but they are frequently 
      uncertain about interpretation of the laboratory tests for the disease. Most 
      would not recommend universal screening of pregnant women.
FAU - Jones, J L
AU  - Jones JL
AD  - Centers for Disease Control and Prevention, Atlanta, GA 30341-3724, USA. 
      JLJ1@CDC.gov
FAU - Dietz, V J
AU  - Dietz VJ
FAU - Power, M
AU  - Power M
FAU - Lopez, A
AU  - Lopez A
FAU - Wilson, M
AU  - Wilson M
FAU - Navin, T R
AU  - Navin TR
FAU - Gibbs, R
AU  - Gibbs R
FAU - Schulkin, J
AU  - Schulkin J
LA  - eng
PT  - Journal Article
PL  - Egypt
TA  - Infect Dis Obstet Gynecol
JT  - Infectious diseases in obstetrics and gynecology
JID - 9318481
RN  - 0 (Immunoglobulin M)
SB  - IM
MH  - Acute Disease
MH  - False Positive Reactions
MH  - Female
MH  - Gynecology/education
MH  - Humans
MH  - Immunoglobulin M
MH  - Male
MH  - Mass Screening
MH  - Middle Aged
MH  - Obstetrics/education
MH  - *Practice Patterns, Physicians'
MH  - Pregnancy
MH  - Surveys and Questionnaires
MH  - Toxoplasmosis/*diagnosis/epidemiology/prevention & control
PMC - PMC1784635
EDAT- 2001/05/23 10:00
MHDA- 2001/10/12 10:01
PMCR- 2001/01/01
CRDT- 2001/05/23 10:00
PHST- 2001/05/23 10:00 [pubmed]
PHST- 2001/10/12 10:01 [medline]
PHST- 2001/05/23 10:00 [entrez]
PHST- 2001/01/01 00:00 [pmc-release]
AID - S1064744901000059 [pii]
AID - 10.1155/S1064744901000059 [doi]
PST - ppublish
SO  - Infect Dis Obstet Gynecol. 2001;9(1):23-31. doi: 10.1155/S1064744901000059.